Page 71
International Journal of Emergency Mental Health and Human Resilience | ISSN: 1522-4821 | Volume 20
November 26-27, 2018 | Los Angeles, USA
Psychiatry, Mental Health Nursing and Healthcare
World Summit on
Applied Psychology, Psychiatry and Mental Health
International Conference on
&
Introduction to autism spectrum disorders
Janani Venugopalakrishnan
Stanford University School of Medicine, USA
T
he objective of the talk is to discuss epidemiology, the varied presentation of Autism spectrum disorders (ASD), criteria for
diagnosis, treatment, recent research and discuss resources available to families. Autism spectrum disorders is a common
neurodevelopmental disorder with social deficits including difficulties in verbal and nonverbal communication and restricted
repetitive interests, or behaviors. Hyper or hyposensitivity to sensory stimuli is also commonly seen. It is a heterogeneous disorder,
causation of which can be idiopathic or attributed to genetic mutations, deletions, prematurity, pregnancy or birth complications
and in utero infections. The most recent prevalence of ASD according to the Center for Disease Control is 1 in 59 children as
opposed to 1 in 68 children two years ago which presents increasing medical and social implications. Autism is associated with several
comorbid disorders including mood and behavioral challenges like anxiety, depression, aggression, disruptive behaviors, Attention
deficit hyperactivity disorder and insomnia which often require detailed evaluation and treatment. Intellectual disability, delayed
milestones, speech and language deficits, gross motor and fine motor difficulties are other challenges. Detailed clinical evaluation
and neuropsychiatric testing may be required to establish the diagnosis. There is no single treatment for ASD, however, an array
of interventions inclusive of early behavioral therapy, speech, occupational therapies, exercises and parent training are found to be
helpful. Medications including SSRIs, second-generation antipsychotics, alpha agonists, mood stabilizers and stimulants are used to
help with the associated conditions. Recent medication trials with N-Acetyl-Cysteine, Vasopressin, Oxytocin, have been promising.
School-based interventions inclusive of 504 plans and Individualized education plans (IEP) are beneficial to the student with ASD.
jananiv@stanford.eduInt J Emerg Ment Health, Volume 20
DOI: 10.4172/1522-4821-C5-024